Skip to main content
. 2019 Nov 13;10:1305. doi: 10.3389/fphar.2019.01305

Figure 3.

Figure 3

Alpha-mangostin (α-MG) blocked transforming growth factor-β1 (TGF-β1)/Smad2/3 signaling pathway and regulate MMPs/tissue inhibitor of metalloproteinase (TIMP) system balance in bleomycin (BLM)-induced pulmonary fibrosis. One week after BLM treatment (5 mg/kg), mice were intragastrically administered with α-MG (10 mg/kg) or nintedanib (40 mg/kg) once a day for 14 days. Mouse lungs were collected on day 21 after BLM treatment. Protein expression of MMP-9 (A), TIMP-1 (B), TGF-β1 (C), and p-Smad2/3 and Smad2/3 (D) were detected using Western blot analysis. Data were expressed as mean ± SD (n ≥ 3). *p < 0.05, **p < 0.01, ***p < 0.001, NS, non-significant.